Cannabis Science Inc. (OTCPK:CBIS), a maker of cannabis-based medicines, published a press note, as per which, it announced successful completion of a visit to South Africa by its delegation.
This African healthcare infrastructure delegation was headed by Mr. Raymond Dabney while Dr. Julius Garvey, CBIS Scientific Advisory Board member, Dr. Allen Herman, Chief Medical Officer, and Mr. Melvin Foote, President & CEO of Constituency for Africa accompanied him during the visit.
Cannabis Science noted the delegation met its primary objective during the visit and is now working on the next phase of development, as well as another trip to progress ahead with its implementation programs. Dr. Herman said that the short trip to South Africa and Namibia, marked the start of the company’s partnership with the intellectual, political, educational, clinical leadership and research aspects in the two key regions.
Meetings with key stakeholders
The delegation met with chief stakeholders in Cape Town and Johannesburg, South Africa, which included political parties, Government Ministries, private players, academia and civil society. The company discussed traditional medicines and cannabinoids in the African culture and chalked out plans about collaboration with international regulators to make CBIS cannabinoid pharmaceuticals accessible in the regions and across the continent where more than 1 billion people are historically underserved medically.
Cannabis Science noted that commencement of operations in main Southern African cities would help it to develop its pharmaceutical products and grow a footprint to tap into the vast potential of the entire African medical industry.
Besides this, the delegation had met several leaders in Windhoek, Namibia, where concerns and initiatives around healthcare education and services were extensively discussed. The groups discussed the integral role the the Raymond C. Dabney University could play in education, job creation and further development of safe and effective canabinoids and other phyto-pharmaceuticals to diseases and conditions endemic in the region.
Before concluding the visit, Mr. Dabney entered into a Memorandum of Cooperation with the International University of Management of Namibia as a gesture to facilitate joint educational and research programs there.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of PotNetwork.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://potnetwork.com/legal-disclaimer/.